Acute lymphoblastic leukaemia trials in United States

In United States 232 Also abroad 564

232 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
Where
Houston
Age
12 years to 80 years
People
80
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT05092451
No phaseTaking people
Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)
Where
Chapel Hill
Age
6 years and over
People
40
Run by
UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07634653
No phaseEnrolling by invitation
VR-PAT During Home Burn Dressings - Multisite
Where
Columbus, Dallas
Age
6 years to 17 years
People
220
Run by
Nationwide Children's Hospital
See details and how to joinNCT05673551
No phaseNot yet taking people in United States
PRAISE-IR Versus CIBMTR Controls
Where
New York
Age
1 year to 66 years
People
51
Run by
Miltenyi Biomedicine GmbH
See details and how to joinNCT07717164
No phaseTaking people
Multicenter HomeVENT: Home Values and Experiences Navigation Track
Where
Baltimore, New Orleans, Seattle, Tampa
Age
18 years and over
People
600
Run by
Johns Hopkins University
See details and how to joinNCT06102330
Phase 2Taking people
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
Where
Charlotte, Memphis, Tulsa
Age
1 year to 18 years
People
128
Run by
St. Jude Children's Research Hospital
See details and how to joinNCT06533748
No phaseTaking people
Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
Where
Memphis
Age
18 years and over
People
188
Run by
St. Jude Children's Research Hospital
See details and how to joinNCT06747910
Phase 1/2Taking people
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
Where
Houston
Age
18 years and over
People
276
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT01371630
Phase 4Taking people
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Where
Baton Rouge, Charlotte, Memphis, San Diego, Tulsa
Age
1 year to 18 years
People
850
Run by
St. Jude Children's Research Hospital
See details and how to joinNCT06289673
No phaseTaking people
Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia
Where
Chicago
Age
15 years and over
People
48
Run by
University of Chicago
See details and how to joinNCT06446661
No phaseTaking people
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
Where
Philadelphia
Age
Up to 25 years
People
50
Run by
Children's Hospital of Philadelphia
See details and how to joinNCT03810196
No phaseNot yet taking people in United States
Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALL
Where
Kansas City
Age
2 years to 12 years
People
20
Run by
University of Kansas Medical Center
See details and how to joinNCT06050850
Phase 1Taking people
Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
Where
Philadelphia
Age
0 years to 29 years
People
33
Run by
Stephan Grupp MD PhD
See details and how to joinNCT06934382
No phaseTaking people
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Where
Akron, Amarillo, Ann Arbor, Atlanta, Augusta, Aurora, Baltimore, Beech Grove, Bethesda, Birmingham, Boston, Brandywine, Buffalo, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Denver, Detroit, Duarte, Durham, Fort Sam Houston, Fort Worth, Gainesville, Gilbert, Glendale, Grand Rapids, Hackensack, Hershey, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kansas City, La Jolla, Lake Sucess, Little Rock, Loma Linda, Los Angeles, Louisville, Lubbock, Madison, Maywood, Memphis, Miami, Milwaukee, Morgantown, Nashville, New Brunswick, New Haven, New Hyde, New Orleans, New York, Oakland, Oklahoma City, Omaha, Orange, Orlando, Park Ridge, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Richmond, Rochester, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Seattle, Sioux Falls, Stanford, St Louis, Stony Brook, St. Petersburg, Tampa, The Bronx, Tucson, Washington D.C., Westwood, Winston-Salem, Worcester, Zion
People
99,999
Run by
Center for International Blood and Marrow Transplant Research
See details and how to joinNCT01351545
Phase 2Taking people
Allo HSCT Using RIC and PTCy for Hematological Diseases
Where
Minneapolis
Age
Up to 75 years
People
56
Run by
Masonic Cancer Center, University of Minnesota
See details and how to joinNCT05805605
No phaseTaking people
Halt Aging in Survivors of Blood Cancers
Where
Omaha
Age
50 years and over
People
180
Run by
University of Nebraska
See details and how to joinNCT07292272
No phaseTaking people
Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
Where
Chicago
Age
14 years and over
People
60
Run by
Northwestern University
See details and how to joinNCT03932903
No phaseTaking people
Registry of Older Patients With Cancer
Where
Boone, Chapel Hill, Greenville, Hendersonville, Morehead City, New Bern, Raleigh
Age
65 years and over
People
3,000
Run by
UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137825
Phase 1Taking people
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
Where
Chicago, Dallas
Age
18 years to 39 years
People
15
Run by
University of Chicago
See details and how to joinNCT03571321
Phase 2Taking people
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Where
Duarte
Age
18 years to 80 years
People
35
Run by
City of Hope Medical Center
See details and how to joinNCT06815003
Phase 2Taking people
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Where
Minneapolis
Age
Up to 60 years
People
300
Run by
Masonic Cancer Center, University of Minnesota
See details and how to joinNCT03314974
No phaseEnrolling by invitation
Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
Where
Bethesda
Age
18 years to 120 years
People
136
Run by
National Cancer Institute (NCI)
See details and how to joinNCT07499128
Phase 1Taking people
Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
Where
Palo Alto
Age
18 years to 70 years
People
24
Run by
Stanford University
See details and how to joinNCT06551584
Phase 1/2Taking people
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
Where
Seattle
Age
18 years to 75 years
People
75
Run by
Fred Hutchinson Cancer Center
See details and how to joinNCT03128034
Phase 1/2Taking people
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
Where
Seattle
Age
18 years to 75 years
People
30
Run by
Fred Hutchinson Cancer Center
See details and how to joinNCT03670966